All Press Releases
PILA PHARMA AB Chairman & CEO increase their holdings
Malmö, 19 November 2024 PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company"), (FN STO: PILA), today announces that Chairman of the Board, Dorte X. Gram and CEO Gustav H. Gram have purchased additional shares. The purchases were conducted in two separate entities.Firstly, PILA PHARMA Chairman of the Board, Dorte X. Gram, together with CEO Gustav H. Gram, have acquired additional…
PILA PHARMA TO PARTICIPATE IN DANISH INVESTMENT PODCAST “MILLIONÆRKLUBBEN”
Malmö, 14 November 2024 PILA PHARMA AB (publ) (FN STO: PILA) hereby invites you to view and/or listen to the broadcast from todays episode of "Millionærklubben" (Millionaire's Club) where PILA PHARMA's CEO Gustav H. Gram will participate. CEO Gustav H. Gram is invited to elaborate on PILA PHARMA and answer questions from the experts and listeners about the rationale of the…
PILA PHARMA ANNOUNCES SELECTION OF CLINICAL TRIAL SITE AND DECISION TO SEEK SCIENTIFIC ADVICE FOR OPTIMIZED PP-CT03 STUDY DESIGN
Malmö, 14 November 2024 PILA PHARMA AB (publ) (FN STO:PILA) today announces the selection of the principal investigator, Professor Mark Evans and Cambridge University Hospital as principal clinical trial site for the conduct of PP-CT03 as well as the as having decided to seek further scientific advice as first step. On 17 October, PILA PHARMA informed of optimization changes to the…